Zonisamide MINImix™ Tablet
Zonisamide is a compounded formulation containing Zonisamide, prepared by Mixlab for veterinary use. Available by prescription.
MINImix Tablets are tiny tablets made for easy swallowing and accurate dosing—perfect when only a small amount of medicine is needed.
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Zonisamide is a sulfonamide anticonvulsant utilized in veterinary medicine for its ability to manage neuronal signaling. It is a prescription medication available for use in dogs and cats, frequently considered in the context of neurological health for managing seizures. Your veterinarian will determine appropriateness based on specific diagnostic imaging or EEG results.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it manages seizure activity by blocking sodium and calcium channels while enhancing GABA signaling. Commonly observed effects include behavioral shifts such as temporary lethargy, coordination changes (ataxia) or a decrease in appetite. Because it is a sulfonamide, your veterinarian will monitor for observational signs of skin sensitivity or hematological shifts through regular blood tests. Owners should monitor for significant behavioral changes and contact their veterinarian promptly with any concerns.
Yes. Zonisamide is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before Preparing any medication.
Yes. Mixlab specializes in compounding zonisamide into customized strengths and flavored oral formats, such as flavored oral liquids or treats, to support easier administration for your pet.
Veterinarians discuss zonisamide because it is studied for its influence on abnormal electrical activity in the brain. This may be considered in the context of managing seizure frequency and supporting your pet's quality of life.
Sedation and staggering are commonly observed effects, especially when first starting. Your veterinarian will provide guidance on what behavioral shifts are expected during the recovery phase.
Your veterinarian will recommend periodic blood work to monitor the physiological response and overall health. This monitoring ensures the management approach remains safe and suitable.
